{"id":"W3203942868","doi":"10.1007/s41669-021-00300-8","title":"Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Evolocumab; Medicine; Ezetimibe; Familial hypercholesterolemia; Dyslipidemia; Statin; Internal medicine; Quality-adjusted life year; Alirocumab; Cost effectiveness; Cholesterol; Disease; Lipoprotein","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004094328,0.0007510053,0.0009384767,0.0009998374,0.0001563851,0.0009589933,0.000622208,0.0007633923,0.003250927],"category_scores_gemma":[0.01249065,0.0003783033,0.002387794,0.0006814136,0.0002851455,0.0006586639,0.0007666675,0.0007850867,0.0001183241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00564916,"about_ca_system_score_gemma":0.003029227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02961736,"about_ca_topic_score_gemma":0.01632224,"domain_scores_codex":[0.9982685,0.001340326,0.00007423397,0.00008363887,0.0001215796,0.0001116225],"domain_scores_gemma":[0.9944885,0.003971975,0.0007001341,0.0001070315,0.0004275216,0.0003048391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0358463,0.001156921,0.07747707,0.004689063,0.009855717,0.001032762,0.0002741457,0.7813304,0.001982312,0.006814487,0.003982415,0.07555829],"study_design_scores_gemma":[0.01001398,0.01258378,0.08414384,0.00208449,0.01276711,0.001320002,0.0009777793,0.8644638,0.001912387,0.004263435,0.005308332,0.0001610844],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762271,0.01362681,0.003129871,0.001799494,0.00008077098,0.0003586441,0.002040824,0.00003283713,0.002703804],"genre_scores_gemma":[0.997135,0.00124694,0.0008320912,0.0001145905,0.00001055125,0.00005789738,0.0004066803,0.000002907893,0.0001933376],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02961736,"threshold_uncertainty_score":0.05888993,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1132914764465246,"score_gpt":0.427569372084309,"score_spread":0.3142778956377844,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}